The video trainings provided here were created by staff and faculty at the University of Washington’s Addictions, Drug & Alcohol Institute and the UW School of Medicine, along with community partners.

Medications

Long Acting, Injectable Buprenorphine for Opioid Use Disorder

Presenters: Addy Adwell, RN-B, BSN and Kristie Drenckpohl, RN-BC, CARN

During this presentation, Addy Adwell, RN-BC, BSN and Kristie Drenckpohl, RN-BC, CARN discussed use of injectable buprenorphine for the treatment of opioid use disorder, including practical tips starting and supporting patients on this medication. (April 2021)

Low Dose Buprenorphine Induction for Pain and Opioid/Fentanyl Use Disorder

Presenter: Matt Perez, MD

During this presentation, Dr. Perez will discuss methods to start buprenorphine without a period of withdrawal for patients unable to do a traditional start or those using fentanyl and review potential benefits of transitioning chronic non-cancer pain patients on long-term opioids to buprenorphine. (February 2021)

Medications for Opioid Use Disorder in Washington State Jails

Part 1: Opioid Use Disorder & Medications for Opioid Use Disorder

Presenter:  Mandy Owens, PhD, UW Addictions, Drug & Alcohol Institute (ADAI)

The first module in this training provides a brief introduction to opioid use disorder and medications for opioid use disorder. This module is intended for a jail staff audience, including corrections officers. It discusses: the important distinction between opioid dependence and opioid use disorder; the three FDA-approved medications, methadone, buprenorphine, and naltrexone; and common concerns related to medications for opioid use disorder.

Part 2: The Role of Medications for Opioid Use Disorder in Jails

Presenters: Lt. Penelope Sapp (Kitsap County Jail), Comm. Stephen Sultemeier (Franklin County Jail), and Mandy Owens, PhD (UW ADAI).

This second module of the training series includes the testimonies from two Washington State jails, the Kitsap County Jail and Franklin County Jail. Lt. Sapp and Comm. Sultemeier offer their rationales for starting an MOUD program at their facilities. They discuss the benefits they have seen of an MOUD program to the people who incarcerated, jail staff, and their communities. Last, Dr. Owens describes how starting people on MOUD can reduce their risk of overdose after release from jail.

Part 3: Common Concerns Related to Medications for Opioid Use Disorders in Jails

Presenters: Lt. Penelope Sapp (Kitsap County Jail), Victor Mendez (Family Health Centers – Omak), and Mandy Owens, PhD (UW ADAI)

This third module of the training series addresses common concerns related to MOUD programs in jails, including: “Aren’t you replacing one drug for another?”, “What about diversion?”, and “I just see the same people coming back to jail”. Dr. Owens reviews the difference between opioid dependence and opioid use disorder that was discussed in Part 1. Lt. Sapp returns to share how the benefits of their MOUD program have outweighed risks of diversion. In conclusion, Victor shares his story that includes 25 years of incarceration, but how MOUD helped him recover from opioid use disorder.

Opioid Use Disorder Medications and Shared Decision Making

Presenter: Paul Barry

This module addresses the importance of shared treatment decision making by clients and providers for the treatment of opioid use disorder. The module includes: why it’s important that clients are informed and involved in their treatment decisions; three guiding principles for shared decision making; issues clients might face in making treatment decisions including stigma; OUD versus opioid dependence; benefits of medications for OUD; descriptions of medications for treating OUD and the potential treatment locations; how to support a client in decision making and forming a treatment plan; the importance of addressing client treatment planning quickly; and resources for providers and clients.

Three learning objectives (from the presentation):

  1. Understand that clients deserve a choice in deciding on treatment,
  2. Remember how to help clients in making this decision,
  3. Recognize some common issues in discussing each medication for OUD.

Treatment Models and Approaches

How to Re-Energize Your Team: Strategies to Encourage and Use Patient Feedback

This 4-hour training focused on how to collect, share, and incorporate patient stories and feedback into your program and sharing patient feedback with partnering organizations. (September 2021)

Powerhouse Panel: Networking and Working with Opioid Treatment Programs

During this presentation, a panel of experts discusses and answers questions about collaborating effectively with opioid treatment programs. (June 2021)

Introduction to the Medication-First Model for Opioid Use Disorder Treatment with Buprenorphine

Presenters: Mark Duncan, MD and Caleb Banta-Green, PhD, MPH, MSW

During the presentation Mark Duncan, MD and Caleb Banta-Green, PhD, MPH, MSW discussed the Medication-First Model. This model aims to address the underlying issues around why less than a quarter of people with OUD are on medications. Many programs are designed to serve the clients most “motivated” to reduce/stop their illicit opioid use. But these criteria have the perverse effect of excluding large proportions of people who DO want to reduce/stop use, but cannot initiate or sustain care in traditional appointment based health care settings.

Addressing Treatment Lapses

Presenter: Addy Adwell

This module discusses treatment lapses in a hopeful, patient-centered approach. While the target audience is care managers, it would be helpful for everyone. This module addresses: that opioid use disorder is a chronic and treatable disease; genetic, environmental, and physical parts of opioid use disorder risk/protection; emphasizes that return to use (relapse) is a normal and expected event and provides a learning opportunity; warning signs of potential return to use; strategies for addressing return to use; reducing shame and stigma; and identifying when and how to adjust treatment. (15 slides).

Three learning objectives (from the presentation):

  1. Understand opioid use disorder as a chronic disease,
  2. Identify risk factors for recurrence of use,
  3. Identify why and how to discuss recurrence of use with patients.
Supporting Transitions Between Treatment Settings

Presenter: Addy Adwell

This module focuses on if/when to transition patients to higher or lower levels of care. It includes: why a treatment transition decision is a clinical judgement best done by a team (and the patient); patterns of behavior that might indicate a need for a higher or lower level of care; descriptions of treatment transition options such as medically supervised withdrawal, inpatient treatment, Opioid Treatment Programs; how to work with the patient to plan for treatment transition, including harm reduction strategies; a list of tasks and the importance of clarifying who is responsible for each of them; and transition options for stable patients.

Three learning objectives (from the presentation):

  1. Identify when to consider a treatment transition,
  2. Understand available treatment options,
  3. Identify risks and benefits of transitioning treatment,
  4. Discuss how to use team to support patient during treatment transition.
Trauma-Informed Care

Presenter: Paul Barry

This module focuses on the impact of trauma on people seeking treatment for SUD/OUD. The module includes: a brief introduction to ACEs (adverse childhood experiences) and how that impacts physical and emotional health; trauma history and co-occurring mental health and substance use disorders; how trauma impacts the brain and how that can impact behavior (fight/flight/freeze, trust); the role of the provider in working with clients with a trauma history; things to avoid when working with people with a trauma history; how to create a safe clinical environment; tips for engaging with clients with a trauma history and the importance of a strengths-based assessment; and tips for calming a client. (25 slides).

Three learning objectives (from the presentation):

  1. Recognize how trauma changes physical and emotional development,
  2. Explain how trauma impacts people’s behavior,
  3. Describe some ways to help people feel safe.
Skills for Community Engagement

Presenter: Paul Barry

This module focuses on building and maintaining referral networks to better serve clients. The module includes: viewing referral networks as collaborative, reciprocal relationships in the community; strategies for building a referral network; the importance of preparing and coaching clients for referring to other agencies for care including barriers and successes; when a higher or different kind of care might be needed; challenges and barriers in bridging care and strategies for addressing them; types of referrals a client might need; the importance of client self-management; and resources. (23 slides).

Three learning objectives (from the presentation):

  1. Understand how to develop and maintain a successful system of resource referrals,
  2. Recognize when intensification of services is warranted,
  3. Describe how to bridge care successfully.

Psychiatry Care for Patients with Opioid Use DIsorder

Assessing ADHD and Schizoaffective Disorder in Patients with OUD

Presenter: Mark Duncan, MD

This webinar reviews the criteria to diagnose bipolar disorder, psychotic disorders, and ADHD in patients with OUD and how to differentiate between substance-induced symptoms and primary mental health disorders. 

Managing Antipsychotics and Mood Stabilizers in Patients with OUD

Presenter: Mark Duncan, MD

Learn when and how to use antipsychotics and mood stabilizers for mental health disorders and methamphetamine use disorder. 

Managing Benzodiazepines and Stimulants in Patients with OUD

Presenter: Mark Duncan, MD

This webinar reviews how to prescribe and manage benzodiazepines and stimulant medications for mental health disorders in the context of OUD.

Addressing Psychiatric Polypharmacy in Patients with OUD

Presenter: Mark Duncan, MD

Learn how to assess a patient’s mental health polypharmacy and apply a shared medical decision-making framework to address polypharmacy. 

Other Topics

Blake Response Seminar Series

In response to the State v. Blake decision earlier in 2021, the Washington State Legislature passed SB 5476 to address justice system responses to substance use and expand behavioral health prevention, treatment, and related services. This multi-part series will begin with an overview of SB 5476 and then provide ongoing updates to its various components.

Session 1: Overview of SB 5476. Presenters Rep. Lauren Davis and Tony Walton, Health Care Authority discuss the main components and intentions behind the bill. (November 2021).

Watch Session 1

Session 2:  Law Enforcement Training Development. Presenters Melodie McKee, MS, SUDP and Mandy Owens, PhD talk about another component of SB 5476 which specifically outlines a requirement for law enforcement training. (December 2021)

Watch Session 2

Future sessions will be added here as they are completed. 

What's Up With Drugs? Increases in Methamphetamine and Fentanyl

In this presentation, Caleb Banta-Green, PhD, MPH, MSW provided an overview of current drug trends with Washington State with a focus on fentanyl, methamphetamine, and overdoses. Download slides. (November 2021)

Stimulant Use Disorder Conference

Presenters: Ann Bruce, MD, Mandy Owens, PhD, Mark Duncan, MD, Michelle Peavy, PhD

This half-day training explores approaches to effectively address stimulant use among individuals being treated for opioid use disorder. Presenters discuss psychological and medication treatment options and a shared decision-making model and apply these topics to a real-world patient case study.  (March 2021)

HIV Care and Prevention for People Who Use Drugs

This presentation focused on HIV case management and prevention best practices for individuals who use drugs and who live in rural and underserved areas. This is a solutions-forward approach for front line providers and client advocates. (May 2021)

Hepatitis C Screening & Treatment for People Who Use Drugs

Presenter: Judith Tsui, MD, MPH

In this presentation, Dr. Tsui discussed Hepatitis C screening and treatment for people who use drugs. (January 2021)

Illicit Fentanyl in Washington State- Trends in Law Enforcement, Treatment, and Overdose

Presenter: Caleb Banta-Green, PhD, MPH, MSW

This presentation covers many aspects of illicit fentanyl products, including the different forms they can appear in. The rise in use and overdoses are described, as well as reasons for these changes. Implications for overdose prevention and initiating treatment with medications for opioid use disorder are described.

Funding for these videos was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA).